RavehYSimkinsJViannaRTekinANicolau-RaducuR. A less restrictive policy for liver transplantation in coronavirus disease 2019 positive patients, based upon cycle threshold values. Transplant Proc. 2021;53(4):1126-1131. doi:10.1016/j.transproceed.2021.01.035
3.
KuteVBFleetwoodVAMeshramHSGuenetteALentineKL. Use of organs from SARS-CoV-2 infected donors: is it safe? A contemporary review. Curr Transplant Rep. 2021;8(4):281-292. doi:10.1007/s40472-021-00343-0
4.
KuteVMeshramHSFleetwoodVAChauhanSLentineKL. Solid organ transplantation in SARS-CoV-2 recovered transplant candidates: a comprehensive review of recent literature. Curr Transplant Rep. 2022:1-13. doi:10.1007/s40472-022-00362-5
5.
ShettyKLominadzeZSahariaK, et al.Clinical practice issues for liver transplantation in COVID-19 recovered recipients. Prog Transplant. 2022;15269248221092742. doi:10.1177/15269248221092742
BerenguaCLópezMEstebanM, et al.Viral culture and immunofluorescence for the detection of SARS-CoV-2 infectivity in RT-PCR positive respiratory samples. J Clin Virol. 2022;152:105167. doi: 10.1016/j.jcv.2022.105167
8.
NatoriYAnjanSMartinEF, et al.When is it safe to perform abdominal transplantation in patients with prior SARS-CoV-2 infection: a case series. Clin Transplant. 2021;35(12):e14370. doi:10.1111/ctr.14370
9.
RavehYLJViannaRNicolau-RaducuR. Protective equipment for liver transplantation in SARS-CoV-2 polymerase chain reaction-positive convalescing recipients. Trans Proceeding. In Press;2022.
